REG - Directa Plus PLC - Posting of Annual Report and Notice of AGM

Directa PlusAnnouncement

23/05/2019 07:05

RNS Number : 9166Z
Directa Plus PLC
23 May 2019
 


23 May 2019
 
Directa Plus plc
("Directa Plus" or the "Company")
 
Posting of Annual Report and Notice of Annual General Meeting
 
Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets-based products for use in consumer and industrial markets, announces that the Company's Annual Report and Accounts for the year ended 31 December 2018, together with the notice of the Company's annual general meeting ("AGM") have been posted to shareholders and are available on the Company's website at www.directa-plus.com.
 
The AGM of the shareholders of the Company will be held on Tuesday 18 June 2019 at 12.00pm BST at 11-12 St James's Square, London SW1 4LB. 
 
For further information please visit http://www.directa-plus.com/ or contact:
 



Directa Plus plc


+39 02 36714458




Giulio Cesareo, CEO


 




Marco Ferrari, CFO


 




 


 




Cantor Fitzgerald Europe (Nominated Adviser and Joint Broker)


+44 20 7894 7000




Rick Thompson, Philip Davies, Will Goode (Corporate Finance)


 




Caspar Shand Kydd (Sales)


 




 


 




N+1 Singer (Joint Broker)


+44 20 7496 3069




Mark Taylor, Lauren Kettle


 




 


 




Tavistock (Financial PR and IR)


+44 20 7920 3150




Simon Hudson, Edward Lee, Barnaby Hayward


 



 
About Directa Plus
Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product) and textiles (based on our G+ products). In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+ products.  All our products are hypoallergenic, non-toxic and sustainably produced.
 
-ends-




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCPGUPPAUPBGBP